[
    [
        {
            "time": "2023-03-05",
            "original_text": "药明康德：约3.48万股限制性A股股票已解除限售并于3月5日上市",
            "features": {
                "keywords": [
                    "药明康德",
                    "限售股",
                    "解除限售",
                    "上市"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德：约3.48万股限制性A股股票已解除限售并于3月5日上市",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-03-05",
            "original_text": "北向资金今日净流入近37亿元，净卖出药明康德5.54亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "净流入",
                    "净卖出",
                    "药明康德"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金今日净流入近37亿元，净卖出药明康德5.54亿元",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-03-05",
            "original_text": "医药行业一周观察：龙头延续回调趋势 关注二线投资机会",
            "features": {
                "keywords": [
                    "医药行业",
                    "回调趋势",
                    "二线投资机会"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业一周观察：龙头延续回调趋势 关注二线投资机会",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-05",
            "original_text": "东吴证券 - 医药生物行业：新冠疫苗逐步获批，巨大期权有望加速兑现",
            "features": {
                "keywords": [
                    "东吴证券",
                    "医药生物",
                    "新冠疫苗",
                    "获批",
                    "期权兑现"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东吴证券 - 医药生物行业：新冠疫苗逐步获批，巨大期权有望加速兑现",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-03-05",
            "original_text": "[异动股] 药明康德(02359-HK)涨7.61%",
            "features": {
                "keywords": [
                    "异动股",
                    "药明康德",
                    "涨7.61%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[异动股] 药明康德(02359-HK)涨7.61%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]